Carboxyl methylation of the C-terminal prenylated cysteine, which occurs in most farnesylated and geranylgeranylated proteins, is a reversible step and is implicated in the regulation of membrane binding and cellular functions of prenylated proteins such as GTPases. The gene coding for prenylated-protein carboxyl methyltransferase (PPMT) of the protozoan parasite Trypanosoma brucei has been cloned and expressed in the baculovirus\Sf 9 cell system. The protein of 245 amino acids has 24-28 % sequence identity to the orthologues from other species including human and Saccharomyces cere isiae. Methyltransferase activity was detected in the membrane fraction from Sf 9 cells infected with the recombinant baculovirus using N-acetyl-Sfarnesylcysteine (AFC) and S-adenosyl [methyl-$H] 
INTRODUCTION
The protozoan parasite Trypanosoma brucei is the causative agent of African sleeping sickness and the cattle disease nagana. Prenyl modification of proteins by C "& farnesyl and C #! geranylgeranyl groups occurs in most eukaryotes, including protozoan parasites such as trypanosomatids [1] [2] [3] . We have previously shown that protein farnesyltransferase inhibitors are generally much more toxic to protozoan parasites than to mammalian cells [4, 5] . This strongly suggests that blocking functional maturation of farnesylated proteins is an excellent strategy for the development of anti-parasite therapeutics.
Membrane targeting and cellular functioning of most prenylated proteins such as Ras superfamily GTPases require further processing steps following prenyl modification [6] [7] [8] [9] . After modification with a farnesyl or a geranylgeranyl group, proteins that contain the C-terminal CaaX motif (C is cysteine, a is usually but not always an aliphatic amino acid, X is a variety of 20 different amino acids) undergo removal of the last three amino acids (aaX) by specific endoprotease(s), Ras-converting enzyme 1 and\or a-factor-converting enzyme 1, present in the endoplasmic reticulum [9, 10] . Subsequently, the α carboxyl group of the newly exposed prenylcysteine is methylated by prenylatedprotein carboxyl methyltransferase (PPMT) that is also associated with the endoplasmic reticulum [11, 12] . MS analysis and metabolic labelling studies with radioactive methionine have shown that most of the prenylated proteins analysed, except for Rab proteins with the C-terminal doubly geranylgeranylated CC motif, are carboxyl methylated [13] . For some proteins, the additional modification with a palmitoyl ester at their C-termini is required for membrane translocation [14] . C-terminal carboxyl methylation and palmitoylation are thought to be reversible steps and therefore have been implicated in the regulation of membrane binding and cellular functions of prenylated proteins. Studies with farnesylated and geranylgeranylated short peptides have shown that tight membrane binding of farnesylated peptides requires carboxyl methylation [15, 16] . Carboxyl methylation of farnesylated transducin γ subunit is important for membrane binding of the βγ dimer and for its association with the α subunit and effector proteins [17] . However, no significant effect of carboxyl methylation was observed for doubly geranylgeranylated Rab 3A protein on its membrane binding and on its interaction with regulatory proteins [18] .
Human and Saccharomyces cere isiae PPMT genes have been cloned [11, 19] . These enzymes are predicted to contain multiple transmembrane regions. Homozygous gene knockout of PPMT interferes with localization of K-Ras to the plasma membrane in mammalian cells [20] and leads to the death of mouse embryos during gestation [21] . The gene knockout abolishes the enzyme activity in the mouse embryo to methylate both farnesylated and geranylgeranylated protein substrates including doubly geranylgeranylated Rab proteins. This suggests that only one enzyme is responsible for the carboxyl methylation of all types of prenylated protein.
In the present study, we have cloned PPMT from T. brucei. We also report the expression of the enzyme in the baculovirus\Sf 9 cell system and the distinct substrate specificity of T. brucei PPMT compared with that of the mammalian enzyme. 
EXPERIMENTAL

Cloning of T. brucei PPMT
A BLAST search of the GenBank database was carried out with the gene coding for human PPMT (GenBank accession number AF064084). A cDNA fragment that contains high homology to the 3h-end of the human PPMT gene was identified (accession number AQ641910). This fragment includes 689 bp of coding sequence containing a stop codon. The 5h-end of the T. brucei PPMT gene was amplified by PCR using cDNA made with Superscript II reverse transcriptase (Gibco BRL) from the bloodstream form of T. brucei strain 427. The oligonucleotide primers were made to the T. brucei splice leader, 5h-AACG-CTATTATTAGAACAGTTTCT-3h (sense), and to the 5h end of the GenBank2 sequence, 5h-CACCATAGTGTAGTTGAGA-CG-3h (antisense). The PCR product ($ 550 bp) was sequenced and found to contain an initiation codon downstream of the splice leader sequence and a completely overlapping sequence of a 152 bp 3h-end sequence which is identical to the 5h-end sequence of the gene with accession number AQ641910. The full-length DNA of T. brucei PPMT was amplified by PCR based on these sequences using T. brucei genomic DNA as template and the high-fidelity DNA polymerase Pwo (Roche Molecular Biochemicals).
Expression of T. brucei PPMT in the Sf 9/baculovirus system
The plasmid containing full-length T. brucei PPMT DNA was shuttled into pFastBAC (Invitrogen) using BamHI and XbaI. The pFastBAC was subjected to transposition into the bacmid in DH10Bac competent cells (Gibco BRL), and PPMT insertion in the bacmid was confirmed by PCR, according to the manufacturer's instructions. After amplification, the baculovirus was subjected to plaque purification by the procedure described in [22] . The purified baculovirus was amplified three times to a final titre of 3i10) plaque-forming units\ml.
For large-scale expression of recombinant T. brucei PPMT, Sf 9 insect cells were cultured at 27 mC with stirring at 120 rev.\min in 200 ml of Grace's medium supplemented with 10 % fetal bovine serum and 10 ml\l chemically defined lipid concentrate (Gibco BRL) in a 500 ml spinner flask. The baculovirus carrying the T. brucei PPMT gene was infected into Sf 9 cells at a multiplicity of infection of 3. After culturing for 60 h, the cells were collected by centrifugation and frozen at k80 mC. The frozen cells were thawed on ice in 20 ml of lysis buffer (50 mM Tris\HCl\1 mM EDTA, pH 7.5) containing freshly added 1 mM dithiothreitol (DTT) and protease inhibitors (1 mM PMSF and 10 µg\ml each of aprotinin, leupeptin and pepstatin A). The cells were disrupted on ice with a Dounce homogenizer (10 strokes). The homogenate was centrifuged at 1000 g for 10 min followed by 10 000 g for 10 min at 4 mC. The supernatant was centrifuged at 120 000 g for 80 min at 4 mC, and the resulting pellet (membrane fraction) was suspended in 1.5 ml of buffer (50 mM Tris\HCl, 1 mM EDTA and 1 mM DTT, pH 7.5) using a Dounce homogenizer. The membrane suspension contained 10.7 mg of protein\ml, and aliquots of the suspension were frozen in liquid nitrogen and stored at k80 mC. The membrane fraction of uninfected Sf 9 insect cells was prepared in the same way.
Preparation of T. brucei membranes
The T. brucei brucei EATRO 140 procyclic form was cultured as described in [4] . The cells from 500 ml of culture (mid-exponential phase) were harvested by centrifugation, washed once with PBS and frozen at k80 mC. The frozen cells were thawed on ice in 10 ml of lysis buffer as described above. The cells were disrupted at 0 mC in a Branson sonicator using a microtip (10i6 s pulses). The lysate was centrifuged at 10 000 g for 10 min, and the supernatant was centrifuged at 120 000 g for 80 min at 4 mC. The resulting pellet (membrane fraction) was suspended in 1 ml of buffer (50 mM Tris\HCl, 1 mM DTT and 1 mM EDTA, pH 7.5) using a Dounce homogenizer at 0 mC. The suspended T. brucei membranes contained 13 mg of protein\ml, and aliquots of the suspension were frozen in liquid nitrogen and stored at k80 mC.
Preparation of mouse liver membranes
Liver (6 g) from four freshly killed C57BL6 mice was minced and homogenized at 0 mC in 18 ml of a lysis buffer (10 mM Tris\ HCl\1 mM EDTA\1 mM DTT\0.25 M sucrose, pH 7.4, containing protease inhibitors as above) using a Potter-Elvehjem homogenizer with a motorized Teflon pestle (three strokes) as described in [23] . The homogenate was centrifuged at 600 g for 10 min, and the supernatant was centrifuged at 12 000 g for 10 min at 4 mC. The resulting supernatant was centrifuged at 120 000 g for 80 min at 4 mC. The pellet was suspended in 1 ml of buffer (50 mM Tris\HCl, 1 mM EDTA and 1 mM DTT, pH 7.5). The suspension of mouse liver membrane contained 27.2 mg of protein\ml, and aliquots of the suspension were frozen in liquid nitrogen and stored at k80 mC.
PPMT assay
Standard reaction mixtures contained 10 µM AFC (1 µl of DMSO solution), 0.625 µM (0.5 µCi) [$H]AdoMet and membrane fraction in 20 µl of buffer (50 mM Tris\HCl, 1 mM EDTA and 5 mM DTT, pH 7.5). Immediately after incubation at 30 mC for 20 min, the reaction mixture was quickly mixed with 200 µl of ice-cold n-heptane by vortexing. After centrifugation at 10 000 g for 1 min, a 150 µl portion of the upper layer was transferred to a new tube. The solvent was removed in acuo, and the dried sample was dissolved in a 30 µl solution of 1 M NaOH\2 % Triton X-100 by brief sonication in a bath sonicator and vortexing. The solution was spotted on a piece of Whatman 3MM filter paper and subjected to [$H]methanol vapour diffusion into 6 ml of scintillation fluid in a glass vial sealed with Parafilm as described in [24] . After incubation for 2-3 h at room temperature, the filter paper was removed, and the vial was subjected to scintillation counting for radioactivity.
Studies on carboxyl methylation of T. brucei cellular proteins in a cell-free system
Cells of the T. brucei bloodstream form were cultured as described in [5] . The cells (2i10)) were suspended in 200 µl of buffer (50 mM Tris\HCl, 1 mM EDTA and 5 mM DTT, pH 7.5) containing protease inhibitors (0.1 mM PMSF and 1 µg\ml each of aprotinin, leupeptin and pepstatin A) and lysed by brief sonication on ice in a Branson sonicator using a microtip. Immediately after sonication, the lysate (10 µl, 8 µg of protein) was incubated at 30 mC for 1 h with 2.5 µM (2 µCi) [$H]AdoMet with vehicle (1 µl of DMSO) or AFC, AGGC or AGC (added as 1 µl of stock solutions in DMSO) in 20 µl of buffer as above. The reaction was terminated by adding 500 µl of ice-cold acetone. The mixture was vortexed and centrifuged at 14 000 g for 10 min at 4 mC. The resulting pellet was air-dried and dissolved in 10 µl of 1 % SDS. After treatment at 100 mC for 3 min with Laemmli sample buffer containing 2 % β-mercaptoethanol, the sample was subjected to SDS\PAGE analysis using a 12.5 % gel. The radioactive protein bands were visualized by fluorography as described in [2] .
Cell growth inhibition assays with T. brucei bloodstream form and mouse 3T3 fibroblasts
AFC, AGGC and AGC were tested for their ability to inhibit the growth of the T. brucei bloodstream form as described in [5] . The effect of the compounds on the growth of 3T3 fibroblasts was quantified with Alamar Blue as described [25] . Stock solutions of the compounds were prepared in DMSO. The final concentration of DMSO in the culture media was 0.25 %, which did not significantly affect growth of T. brucei or fibroblast cells.
RESULTS AND DISCUSSION
Cloning of T. brucei PPMT
By BLAST search of the GenBank database, we identified a 689 bp T. brucei DNA sequence (GenBank accession number AQ641910) whose translated amino acid sequence showed high homology (36 % identity and 57 % homology) to human PPMT (accession number AF064084). This sequence contains a 3h-end fragment of the putative T. brucei PPMT gene. The 5h-end of the gene was amplified from T. brucei cDNA by splice leader RACE (rapid amplification of cDNA ends) [26] , which yielded a product of $ 550 bp. This fragment contains an ATG at 143 bp downstream from the splice leader, which was assumed to be the initiation codon of the gene. Compilation of these overlapping sequences revealed an open reading frame containing 735 bp of the T. brucei PPMT gene. This gene encodes a protein of 245 amino acids with a calculated molecular mass of 28 301 Da (Figure 1 ). Two differences of nucleotide sequence occur in another clone that result in amino acid changes at His-2 to Arg and at Ile-30 to Val. Multiple amino acid sequence alignment of T. brucei PPMT and the orthologues from other species shows extensive homology along most of the length of PPMT (Figure 1) . Amino acid sequence identities between T. brucei PPMT and the enzymes from other species were 24-28 % : S. cereisiae (known as Ste14p ; accession number AAA16840), human (known as pcCMT ; AF064084), rat (AAD42926), Xenopus lae is (BAA19000), Drosophila melanogaster (AE003539), Caenorhabditis elegans (AAB42280) and Dictyostelium discoideum (AAL99548). After completion of this work, the full-length sequence of Leishmania major PPMT appeared in GenBank under accession number AC098797. The Leishmania sequence is 41 % identical to the sequence of T. brucei PPMT. Hydropathy analysis of the full set of PPMTs shown in Figure  1 suggests that all enzymes contain 5-7 predicted transmembrane helices and that two of the N-terminal transmembrane helices are present only in the PPMTs from human, X. lae is, D. melanogaster and C. elegans. Studies by immunofluorescence microscopy and subcellular fractionation have shown that mammalian and yeast PPMTs are localized to the endoplasmic reticulum [11, 12, 27] . Little is known about the active site of this enzyme except for previous studies showing that specific modification of cysteine and possibly lysine and histidine residues by Nethylmaleimide and modification of arginine by phenylglyoxal inactivate the mammalian enzyme [27, 28] . The amino acid sequences of the C-terminal regions are highly homologous among the enzymes from different species (Figure 1) , suggesting that the active site of the enzyme resides in the C-terminal region(s). Several C-terminal residues, namely Arg-139, His-162, Arg-174, His-175 and Arg-212 of T. brucei PPMT, are conserved among the enzymes from all species, and these are found in segments outside of the predicted transmembrane regions, as would be expected for amino acids involved in the active site.
Expression of T. brucei PPMT in the Sf 9/baculovirus system
To examine whether the cloned DNA encodes T. brucei PPMT, a recombinant baculovirus was constructed with the putative T. brucei PPMT open reading frame. SDS\PAGE analysis of membranes prepared from the recombinant PPMT baculovirusinfected cells showed that a protein with an apparent molecular mass of $ 27 kDa was expressed in the infected cells (results not shown). The observed molecular mass of the expressed protein is similar to the calculated molecular mass (28.3 kDa). The sequence contains a predicted signal peptide with a cleavable site at Leu-24.
When membranes from infected cells were assayed for methyltransferase activity using AFC and [$H]AdoMet as substrates, an over-expressed level of enzyme activity was detected compared with the endogenous PPMT activity present in the uninfected Sf 9 cell membranes (Figure 2) . The initial velocity measured with membranes from infected cells was $ 40-fold higher than that detected in the membrane from uninfected cells using the same amount of membrane protein (1 µg). When several baculovirus clones obtained by plaque purification were screened for PPMT expression, levels of the 27 kDa protein expression and the enzyme activity were well correlated (results not shown). The majority of PPMT activity (98.9 % of total activity) was detected in the membrane fraction, and only 1.1 % of the total activity was in the cytosol fraction. These results indicate that the cloned gene encodes a functionally active form of T. brucei PPMT and that the recombinant enzyme associates with membranes.
Substrate specificity of T. brucei PPMT
In mammals, most of the farnesylated and geranylgeranylated proteins are carboxyl methylated at the C-terminal prenyl cysteine [13] . Substrate specificities of recombinant and native T. brucei PPMT with respect to the different prenyl groups (C "! geranyl, C "& farnesyl and C #! geranylgeranyl) were studied using AGC, AFC and AGGC, respectively, as substrates. As shown in Figure 3(A) , when Sf 9 cell membranes (10 µg of protein) containing recombinant T. brucei PPMT were used for the enzyme assays, AFC was found to be a better substrate than AGGC, while AGC was not significantly methylated at concentrations up to 20 µM. The apparent K m values for AFC and AGGC were determined to be 0.17 and 2.3 µM, respectively, and the V max values with AFC and AGGC were 2.7 and 0.7 pmol\min per mg of protein, respectively (Table 1) . Thus recombinant T. brucei PPMT prefers AFC to AGGC by $ 50-fold based on the V max \K m values. Interestingly, the relative catalytic efficiencies (V max \K m ) for AFC and AGGC varied when different amounts of membranes were used. With 1 µg of the Sf 9 cell membrane protein, the V max \K m for AFC was measured to be $ 10-fold higher than the value for AGGC (Table 1) . It is known that geranylgeranylated peptides bind more tightly to synthetic phospholipid vesicles compared with farnesylated peptides [15, 16] . Thus the ratio for the rates of utilization of AFC versus AGGC increases in the presence of a higher amount of membranes, which promotes additional AFC to partition from the aqueous phase into membranes. Therefore, the measured kinetic parameters for the relative catalytic efficiency of AFC versus AGGC are apparent values. Similar substrate specificity was observed with native T. brucei PPMT when the amount of membranes (10 µg of protein) obtained from cells of the T. brucei procyclic form used for assays was the same as the amount of Sf 9 cell membranes containing recombinant enzyme ( Figure 3B and Table 1 ). The native enzyme preferentially utilized AFC over AGGC by $ 40-fold based on values of V max \K m (Table 1) . No significant activity was detected with AGC at concentrations up to 20 µM using native T. brucei PPMT ( Figure 3B ). These results show that the cloned gene encodes T. brucei PPMT. Hasne and Lawrence have detected PPMT activity in membranes from Leishmania dono ani [29] . As for the T. brucei enzyme, Leishmania PPMT prefers AFC over AGGC by $ 7-fold based on values of V max \K m when 15-20 µg of protein was used for the assay : apparent K m values for AFC and AGGC are $ 60 and $ 170 µM, respectively, and the V max values with AFC and AGGC are $ 0.23 and $ 0.1 pmol\min per mg of protein, respectively.
In contrast to these results with trypanosomatid PPMTs, it has been reported that mammalian PPMT from bovine retinal rod membranes utilizes both AFC and AGGC with similar catalytic efficiencies [30] and that PPMT in human neutrophil membranes prefers AGGC to AFC by $ 10-fold [31] . We prepared membranes from mouse liver as a source of mammalian PPMT in order to evaluate its substrate specificity using the same assay conditions as used for T. brucei PPMT. As shown in Figure 3(C) , mouse liver PPMT utilizes AFC slightly better than AGGC. Decreased enzyme activity was observed with high concentrations Table 1 Kinetic parameters of recombinant and native T. brucei PPMT and mouse liver PPMT Sf 9 cell membranes (10 µg of protein) containing recombinant T. brucei PPMT, T. brucei-procyclic-form cell membranes (10 µg of protein) and mouse liver membranes (10 µg of protein) were used for PPMT assays to determine the kinetic parameters. Numbers shown in parentheses for recombinant T. brucei and native mouse liver PPMTs represent the values obtained using 1 µg of protein of the Sf 9 cell membranes and 27 µg of protein of mouse liver membranes, respectively. The K m and V max values (pS.E.M.) were determined by fitting the data to the standard Michaelis-Menten equation using the GraphPad Prism program. of AGGC ( 100 µM) and AFC ( 500 µM). These inhibitory effects of high concentrations of AGGC and AFC were also observed with recombinant and native T. brucei PPMT (results not shown) and may be due to micelle formation of the compounds or to their effects as detergents. Inactivation of PPMT by detergent solubilization was reported for the enzyme in mammalian membranes [31] . We observed that 0.2 % n-octyl β-glucoside caused 55-75 % inhibition of mouse liver PPMT activity when measured with 50 µM AGGC and AFC. The kinetic parameters for mouse liver PPMT were estimated from initial velocities measured with AGGC concentrations 50 µM and with AFC concentrations 200 µM that do not apparently interfere with the enzyme activity. When 10 µg of protein from mouse liver membranes was used for the assay, the apparent K m values were similar for AFC and AGGC ($ 12 µM), and the V max \K m value obtained with AFC was slighly higher (1.3-fold) than the value with AGGC (Table 1) . With a larger amount of mouse liver membranes (27 µg of protein), a higher ratio of V max \K m for AFC versus AGGC utilization (2.3-fold) was observed, as seen with the Sf 9 cell membranes containing recombinant T. brucei PPMT (Table 1) . Thus, it is clear that T. brucei PPMT has an intrinsic preference for AFC over AGGC that is distinctly high compared with mammalian PPMT. It is noteworthy that no significant level of protein geranylgeranyltransferase-I activity was detected in cytosolic fractions from trypanosomatid cells using known substrates of the mammalian enzyme [5, 32] . In addition, while several Rho GTPases are geranylgeranylated in mammals [7, 8] , we have found that a Rho homologue from Trypanosoma cruzi is farnesylated in i o [32] . These data led us to speculate that trypanosomatids may lack protein geranylgeranyltransferase-I. This idea is consistent with the above results that the geranylgeranylated substrate is poorly utilized compared with the farnesylated substrate by T. brucei PPMT (Figures 3A and 3B , and Table 1 ). However, several trypanosomatid Rab homologues have been cloned [33, 34] that may be doubly geranylgeranylated and carboxyl methylated.
Figure 3 Substrate specificity of recombinant (A) and native (B) T. brucei PPMT, and mouse liver PPMT (C)
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Inhibition of protein carboxyl methylation in the T. brucei bloodstream form by AFC in a cell-free system
To detect carboxyl methylation of T. brucei cellular proteins, a lysate of the bloodstream-form cells was incubated with [$H]AdoMet, and radiolabelled proteins were analysed by SDS\ PAGE\fluorography. As shown in Figure 4 (lane 2), the radioactivity was incorporated from [$H]AdoMet into several cellular 
Effects of AFC and AGGC on cell growth of T. brucei bloodstream form
The minimal structural element for mammalian PPMT substrates has been found to be prenylated thiopropionic acid, and the distance between the carboxylic acid and the prenyl group is important [35] . Small compounds, including AFC and AGGC, have been used as competitive substrates for the action of PPMT in cells to investigate the physiological importance of carboxyl methylation of prenylated proteins in i o, although these compounds have also been shown to interfere with other cellular events [36] [37] [38] . AFC-selective inhibition of cellular protein carboxyl methylation observed in the cell-free system of the T. brucei bloodstream form (Figure 4 ) is in accordance with the specificity of T. brucei PPMT ( Figures 3A and 3B , and Table 1 ). Thus, the distinct substrate specificity and relatively low K m values for AFC and AGGC of T. brucei PPMT (low µM) compared with those for the mammalian enzyme (10-35 µM; Figure 4 and Table 1) suggested the possibility that these compounds could inhibit the methylation of parasite-prenylated proteins at concentrations that do not interfere with the methylation of prenylated proteins in mammalian cells. As shown in Figure 5 , AFC and AGGC display 2-fold higher potencies to block the growth of T. brucei bloodstream forms (EC &! l 70-80 µM) than of mouse 3T3 fibroblast cells (EC &! 150 µM). AGGC is slightly more toxic than AFC to both the parasite and mammalian cells. One might anticipate that AGGC is more cell permeable than is AFC. At concentrations of 125 µM, AFC and AGGC nearly completely block T. brucei cell growth, whereas AFC and AGGC inhibit the mammalian cell growth by only $ 5 and 25 %, respectively ( Figure 5 ). AGC that is virtually inactive as a substrate for both T. brucei and mammalian PPMTs ( Figure  3 ), which caused a slight inhibition of T. brucei cell growth at concentrations 125 µM and had no effect on 3T3 cell growth up to 250 µM.
These results suggest that PPMT is a valid anti-parasite drug target. However, it has been shown in mammalian cells that AFC and AGGC can also affect cellular events by mechanisms other than inhibition of PPMT [36] [37] [38] [39] . These small prenylated compounds may competitively block the interaction of prenylated proteins with their acceptor proteins and effector proteins, which makes it difficult to distinguish their effects on PPMT inhibition from other effects. For example, Desrosiers and co-workers [39] have shown that AGGC at concentrations below its critical micellar concentration (340 µM) selectively dissociates geranylgeranylated Rho family proteins and Rab1, but not farnesylated Ras, from mammalian cell membranes. Several prenylated cysteine analogues and S-adenosyl--methionine (AdoMet) analogues have been reported to inhibit PPMT. Among those, the antibiotic sinefungin (an AdoMet analogue) has been shown to be a potent inhibitor of PPMTs from L. dono ani and human neutrophils with K i values of 20 and 70 nM, respectively [29, 31] , although this compound also inhibits other methyltransferases. L. dono ani is reported to be sensitive to this compound [40] . Together, these results, in addition to previous studies of protein farnesyltransferase inhibitors [4, 5] , suggest that the growth of protozoan parasite cells is more susceptible than mammalian cell growth to agents that block the cellular functions of prenylated proteins. Future studies will further explore the potential to exploit T. brucei PPMT as a drug target alone or in combination with inhibiting other steps in the formation of mature prenylated proteins.
